Trends in the Prevalence and Treatment of Diabetic Macular Edema and Vision-Threatening Diabetic Retinopathy Among Commercially Insured Adults Aged <65 Years.

Elizabeth A LundeenMinchul KimDavid B ReinJohn S WittenbornJinan SaaddineJoshua R EhrlichChristopher S Holliday

Published in: Diabetes care (2023)

Annual claims for DME or VTDR and anti-VEGF injections increased whereas those for laser photocoagulation decreased among commercially insured adults with diabetes.

Keyphrases

diabetic retinopathy
optical coherence tomography
type diabetes
cardiovascular disease
risk factors
health insurance
endothelial cells
glycemic control
metabolic syndrome
ultrasound guided
high speed
high resolution
adipose tissue
smoking cessation